近期论文
查看导师最新文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Miao He, Yingzi Fu, Yuanyuan Yan, Qinghuan Xiao, Huizhe Wu, Weifan Yao, Haishan Zhao, Lin Zhao, Qian Jiang, Zhaojin Yu, Feng Jin, Xiaoyi Mi, Enhua Wang, Zeshi Cui, Liwu Fu, Jianjun Chen, Minjie Wei*. The Hedgehog signaling pathway mediates drug response of MCF-7 mammosphere cells and breast cancer patients. Clinical Science (Accepted) (IF5.598)
Ma MT, He M (co-first author), Wang Y, Jiao XY, Zhao L, Bai XF, Yu ZJ, Wu HZ, Sun ML, Song ZG, Wei MJ*. MiR-487aresensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). Cancer Lett. 2013 Oct 1;339(1):107-15 (IF5.016)
Li Z, Huang H, Chen P, He M (co-first author), Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, Zhang Z, Elkahloun A,Cao D, Shen C, Wunderlich M, Wang Y, Neilly MB, Jin J, Wei M, Lu J, Valk PJ, Delwel R, Lowenberg B, Le Beau MM, Vardiman J, Mulloy JC, Zeleznik-Le NJ, Liu PP, Zhang J, Chen J. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun. 2012 Feb 21;3:688. (IF 10.015)
He M, Sun HG, Hao JY, Li YL, Yu JK, Yan YY, Zhao L, Li N, Wang Y, Bai XF, Yu ZJ, Zheng ZH, Mi XY, Wang EH, Wei MJ*. RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation. Oncol Rep. 2013 May;29(5):1721-9(IF 2.191)
He M, Chen P, Arnovitz S, Li Y, Huang H, Neilly MB, Wei M, Rowley JD, Chen J, Li Z. Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia. Blood Cells Mol Dis. 2012 Aug 15;49(2):102-6. (IF2.259)
Wu H, Guan S, Sun M, Yu Z, Zhao L, He M, Zhao H, Yao W, Wang E, Jin F, Xiao Q, Wei M*. Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment. PLoS One. 2015 May 11;10(5):e0126128. (IF 3.534)
Yu Z, Sun M, Jin F, Xiao Q, He M, Wu H, Ren J, Zhao L, Zhao H, Yao W, Shan F, Cao Y, Wei M*. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer. Oncol Rep. 2015 May 8. doi: 10.3892/or.2015.3967. [Epub ahead of print] (IF 2.191)
Ren J, Chen QC, Jin F, Wu HZ, He M, Zhao L, Yu ZJ, Yao WF, Mi XY, Wang EH, Wei MJ*. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer. Int J Clin Exp Pathol. 2014 Aug 15;7(9):5595-608. eCollection 2014. (IF 1.783)
Yu J, Zhao L, Li Y, Li N, He M, Bai X, Yu Z, Zheng Z, Mi X, Wang E, Wei M*. Silencing of fanconi anemia complementation group f exhibits potent chemosensitization of mitomycin C activity in breast cancer cells. J Breast Cancer. 2013 Sep;16(3):291-9. (IF0.773)
Zhao L, Li Y, He M, Song Z, Lin S, Yu Z, Bai X, Wang E, Wei M*. The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells. Int J Oncol. 2014 Jul;45(1):129-38. (IF 2.773)
Zhao L, Li N, Yu JK, Tang HT, Li YL, He M, Yu ZJ, Bai XF, Zheng ZH, Wang EH, Wei MJ*. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion and drug resistance potential of breast cancer cells. Braz J Med Biol Res. 2014 Jan;47(1):24-34(IF 1.034)
Liu M, Chen F, Sha L, Wang S, Tao L, Yao L, He M, Yao Z, Liu H, Zhu Z, Zhang Z, Zheng Z, Sha X, Wei M*. (-)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75NTR Signaling in APP/PS1 Transgenic Mice. Mol Neurobiol. Mol Neurobiol. 2014 Jun;49(3):1350-63. (IF:5.286)
Liu MY, Wang S, Yao WF, Zhang ZJ, Zhong X, Sha L, He M, Zheng ZH, Wei MJ*. Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice. Neuroscience. 2014 Jul 25;273:141-51 (IF 3.327)
Jiao X, Zhao L (co-first author), Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M*. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Breast Cancer Res Treat. 2013 Jun;139(3):717-30 (IF4.198)
Li Z, Huang H, Li Y, Jiang X, Chen P, Arnovitz S, Radmacher MD, Maharry K, Elkahloun A, Yang X, He C, He M, Zhang Z, Dohner K, Neilly MB, Price C, Lussier YA, Zhang Y, Larson RA, Le Beau MM, Caligiuri MA, Bullinger L, Valk PJ, Delwel R, Lowenberg B, Liu PP, Marcucci G, Bloomfield CD, Rowley JD, Chen J. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically-abnormal AML. Blood. 2012, 119(10):2314-24.(IF 9.06)
Li Y, Zhao L, Sun H, Yu J, Li N, Liang J, Wang Y, He M, Bai X, Yu Z, Zheng Z, Mi X, Wang E, Wei M*. Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells. PLoS One. 2012;7(8):e44254. (IF3.73)
Miao He, Minjie Wei*. Reversing multidrug resistance by tyrosine kinase inhibitors, Chinese Journal of Cancer, 2012 Mar;31(3):126-33.
Zhao L, Yu Z, Li Y, Wen X, Ma W, Wang L, Ren J, Liu C, He M, Bai X, Sun M, Zheng Z, Mi X, Wang E, Olopade OI, Jin F, Wei M*. Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women. Medical Oncology, 2012 Sep;29(3):1569-75.(IF 2.147)
Liu M, Chen F, Lin T, Yao L, He M, Zhu Z, Yao Z, Wang S, Yao W, Zhang Z, Tang Q, Wei M*. (-)-Epigallocatechin-3-gallate ameliorates learning and memory impairments by attenuating peroxidation in APP/PS1 transgenic mice. Mol Neurodegener. 2012 Feb 7;7 Suppl 1:S29. (IF 5.091)
Mi S, Li Z, Chen P, He C,Cao D, Elkahloun A, Lu J, Pelloso LA, Wunderlich M, Huang H, Luo RT, Sun M, He M, Neilly MB, Zeleznik-Le NJ, Thirman MJ, Mulloy JC, Liu PP, Rowley JD, Chen J. Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc Natl Acad Sci U S A, 2010 Feb 23;107(8):3710-3715. (IF 9.771)
Miao He, Lin Zhao, Min-Jie Wei*, Wei-Fan Yao, Hai-Shan Zhao, Fu-Jun Chen. Neuroprotective effect of (–)-Epigallocatechin-3-gallate on aging mice induced by D-galactose. Biol.Pharm.Bull.. 2009, 32(1):55-60. (IF 1.81)
He M, Zhao L, Yao WF, Zhao HS, Chen FJ, Wei MJ*. Protective effects of (-)-Epigallocatechin-3-gallate on D-galactose-induced neuronal apoptosis in mice. Neural Regen Res 2009 , 4(12):1024-1029. (IF 0.180)
Lin Zhao, Lin Wang, Jie Ren, Xiaoyan Wen, Miao He, Feng Jin, Wenfeng Ma, Minjie Wei*. Silencing of Estrogen receptor α (ERα) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer, Breast Cancer Research and Treatment. 2009,117(2):253-259. (IF 4.696)
王琳琳,魏敏杰,何苗*. 低氧诱导因子在肿瘤干细胞介导的肿瘤发生发展中的作用. 天津医药,2015,43(6):690-693.
颜媛媛,何苗,魏敏杰*. 内质网应激与肿瘤细胞耐药的相关机制. 中国药理学通报. 2015, 31(4):461-464
江茜,马孟涛,何苗,王岩,焦旭阳,赵琳,于兆进,孙明立,魏敏杰*. 微小RNA-487a调节乳腺癌耐药细胞药物敏感性的作用与机制研究. 山西医药杂志, 2014, 43(16):1879-1882
王俊, 赵琳, 何苗, 魏敏杰*. FANCF基因与肿瘤发生和耐药性形成的研究进展.现代肿瘤医学, 2013, 21(7):1629-1631.
何苗,刘明妍,王爽,唐秋实,姚维凡,赵海山,魏敏杰*. EGCG对化学诱导AD模型小鼠脑部退行性病变的影响.中药材,2012,35(10):1641~1644
吴韬,李艳琳,何苗,魏敏杰*. miRNA对乳腺癌耐药的调控机制. 现代肿瘤医学,2012,20(9):1959-1962.
何苗,魏敏杰*. microRNA在急性白血病中表达谱与作用的研究.现代肿瘤医学,2011,19(4):784~788
唐宏涛,何苗,李娜,孙海刚,余涧坤,郝俊莹,魏敏杰*.FANCF-shRNA表达质粒的构建及MCF-7-FANCF-RNAi瞬时转染细胞模型的建立.中国医科大学学报,2011,40(8):676-680
郝俊莹,孙海刚,李娜,余涧坤,唐宏涛,李艳琳,于兆进,赵琳,何苗,魏敏杰*. FANCF-shRNA质粒构建及其对卵巢癌细胞OVCAR3沉默效应的观察. 中华肿瘤防治杂志, 2011,18(10):741~745
赵琳,于兆进,李宇男,何苗,王麟,任婕,白雪峰,赵海山,姚维范,魏敏杰*. 5-氮杂脱氧胞苷酸诱导ERα, ERβ恢复表达的实验研究. 现代肿瘤医学,2011,19(5):842~845
何苗,魏敏杰*. FANCF基因启动子甲基化在散发性肿瘤的发生和耐药性形成中的作用.现代肿瘤医学, 2008,16(6):1061-1064.
何苗,魏敏杰,赵琳,赵海山,姚维凡. 小刺猴头菌醇提物防治化学诱导的阿尔茨海默病小鼠的作用与机制初探. 中国医科大学学报,2008,37(2):184~186
赵琳,何苗,魏敏杰. 川芎嗪对三氯化铝致阿尔茨海默病模型小鼠学习记忆能力的影响. 中国行为医学科学,2008, 17(10):878-880.
赵琳,魏敏杰,何苗,金万宝,赵海山,姚维凡. 川芎嗪对阿尔采末病模型小鼠学习记忆能力的影响及其机制初探. 中国药理学通报,2008, 24(8):1088-1092.
何苗,赵琳,姚维凡,赵海山,陈福军,魏敏杰. EGCG对D-半乳糖诱导的阿尔茨海默病小鼠的抗凋亡作用. 沈阳药科大学学报,2008,25(增刊):60
何苗,魏敏杰. EGCG防治神经退行性疾病的作用机制. 生命的化学,2007,27(5):434-436.
何苗,魏敏杰*,金 锋,米小轶,任 婕,冯婉玉,金万宝.散发性乳腺癌中FANCF基因和BRCA1基因启动子甲基化关系的研究[J].医药导报,2007,26(增刊):103.
WEI Min-Jie*, HE Miao, JIN Feng, MI Xiao-Yi, FENG Wan-Yu. Relationship of FANCF promoter methylation and BRCA1 promoter methylation in the Chinese sporadic breast cancer. Chin J Pharmacol Toxicol, 2007;21(4):345
教材编写
参编《药物治疗与疾病》,2008年4月《上海科学技术出版社》出版
参编《药事管理学》,2011年8月《上海科学技术出版社》出版